1688O Informative censoring of surrogate end-point data in FDA-approved cancer drugs

Censoring (clinical trials) Surrogate endpoint Clinical endpoint
DOI: 10.1016/j.annonc.2023.09.2642 Publication Date: 2023-10-20T13:08:36Z
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....